David Chonzi | VP, Patient Safety and Risk Management
Kite, A Gilead Company

David Chonzi, VP, Patient Safety and Risk Management, Kite, A Gilead Company

Appearances:



Day One World Drug Safety Congress EU 2018 @ 17:25

Safety measures in CAR T and Cellular Therapy

last published: 13/Aug/18 10:55 GMT

back to speakers